GRNAW GreenLight Biosciences Holdings, PBC - Warrant

GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and a range of crops. The company was founded in 2008 and is based in Medford, Massachusetts.  This security was issued by GreenLight Biosciences Holdings, PBC, whose common stock symbol is GRNA.

$0.22
As of 07/08/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Warrants
Category3:  Operating Companies
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  02/03/2022
Outstanding shares:  0
Average volume:  19,522
Market cap:   $0
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy